Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$----
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
Debt to Equity
--
ROE
--
ROCE
--
Div. Yield
--
Book Value
--
EPS
--
CFO
$-151.37 Mln
EBITDA
$-166.68 Mln
Net Profit
$-147.72 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
XOMA Corporation (XOMAP)
| 0.27 | 1.37 | 1.92 | 4.55 | -0.38 | -- | -- |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
XOMA Corporation (XOMAP)
| 1.83 | 2.45 | -5.70 | 5.24 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and... pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Address: 2200 Powell Street, Emeryville, CA, United States, 94608 Read more
CEO & Director
Mr. Owen P. Hughes Jr.
CEO & Director
Mr. Owen P. Hughes Jr.
Headquarters
Emeryville, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of XOMA Corporation (XOMAP) is $25.95 (NASDAQ) as of 17-Apr-2025 16:00 EDT. XOMA Corporation (XOMAP) has given a return of -0.38% in the last 3 years.
XOMA Corporation (XOMAP) has a market capitalisation of -- as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the XOMA Corporation (XOMAP) and enter the required number of quantities and click on buy to purchase the shares of XOMA Corporation (XOMAP).
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Address: 2200 Powell Street, Emeryville, CA, United States, 94608
The CEO & director of Mr. Owen P. Hughes Jr.. is XOMA Corporation (XOMAP), and CFO & Sr. VP is Mr. Owen P. Hughes Jr..
There is no promoter pledging in XOMA Corporation (XOMAP).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| XOMA Corporation (XOMAP) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of XOMA Corporation (XOMAP) was $0 Mln.
$-0.15
(
